We have shown recently that ET-1 treatment in cultured RGCs resulted in a significant decline in ATP synthase expression, leading to impaired mitochondrial bioenergetics, which could be one mechanism underlying the ET-1-mediated neurodegeneration of RGCs in glaucoma [11]. This evidence concerns the gene EDN1 and glaucoma.